Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)

por Desouza, Cyrus, Kirk, Andreas R, Mangla, Kamal K, Wolden, Michael L, Lingvay, Ildiko
Publicado 2020

Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study

por Lingvay, Ildiko, Kirk, Andreas R., Lophaven, Søren, Wolden, Michael L., Shubrook, Jay H.
Publicado 2021